Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cataracts
U.S. FDA approves AcrySof Toric intraocular lens
October 23rd, 2005
Alcon, Inc., (ACL) announced that the U.S. Food & Drug Administration (FDA) approved the AcrySof Toric intraocular lens (IOL) for use in cataract patients with pre-existing corneal astigmatism. The AcrySof Toric lens is based on the AcrySof single-piece IOL design and acrylic material platform. The lens incorporates an optical design that corrects for pre-existing astigmatism in cataract patients resulting in significantly improved distance visual outcomes, according to the company. "Approval of the AcrySof Toric IOL is an important addition to our AcrySof IOL product portfolio and further demonstrates our commitment to helping cataract surgeons...
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
